Clinical trial
CGM-Phenotyped Circadian Glycemic Vulnerability Windows to Personalize Meal Timing and Postprandial Activity in Prediabetes : A Randomized Controlled Trial
NCT07618663 is registered in ClinicalTrials.gov with Shifa International Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- CGM-Phenotyped Circadian Glycemic Vulnerability Windows to Personalize Meal Timing and Postprandial Activity in Prediabetes : A Randomized Controlled Trial
- Lead sponsor
- Shifa International Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2026
- Completion date
- July 26, 2026
- Enrollment
- 105 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prediabetes, prediabetes (insulin resistance, impaired glucose tolerance), prediabetes or diabetes